Source:http://linkedlifedata.com/resource/pubmed/id/10625113
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2000-2-8
|
pubmed:abstractText |
Some evidence exists to suggest that serotonin 5-HT2A receptor function is altered in anorexia nervosa and bulimia nervosa. In order to further investigate the 5-HT2A receptor in eating disorders, platelet [3H]lysergic acid diethylamide ([3H]LSD) binding was studied in ten patients with anorexia nervosa, 23 patients with bulimia nervosa and 33 healthy controls. At admission, Bmax for platelet [3H]LSD binding was significantly higher both in the anorexia nervosa group (30.6+/-4.2 fmol/mg protein; mean+/-S.D.) and in the bulimia nervosa group (30.8+/-7.6 fmol/mg protein) than in the control group (23.5+/-6.3 fmol/mg protein; p=0.01 and p=0.003, respectively). Kd was borderline significantly higher among anorexics (median 1.45 nM) and significantly higher among bulimics (median 1.66 nM) than among controls (median 0.95 nM; p=0.05 and 0.003, respectively). The Global Assessment of Functioning score and the body mass index were both significantly negatively correlated to Kd (r=-0.40; p=0.03 and r=-0.41 p=0.03, respectively), but not to Bmax. The present study indicates that patients with anorexia nervosa as well as patients with bulimia nervosa have an enhanced 5-HT2A receptor binding and provides further evidence for a serotonergic dysfunction in eating disorders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Lysergic Acid Diethylamide,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT2A,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Antagonists
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0924-977X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
469-73
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10625113-Adolescent,
pubmed-meshheading:10625113-Adult,
pubmed-meshheading:10625113-Analysis of Variance,
pubmed-meshheading:10625113-Anorexia Nervosa,
pubmed-meshheading:10625113-Blood Platelets,
pubmed-meshheading:10625113-Body Mass Index,
pubmed-meshheading:10625113-Bulimia,
pubmed-meshheading:10625113-Female,
pubmed-meshheading:10625113-Follow-Up Studies,
pubmed-meshheading:10625113-Humans,
pubmed-meshheading:10625113-Lysergic Acid Diethylamide,
pubmed-meshheading:10625113-Receptor, Serotonin, 5-HT2A,
pubmed-meshheading:10625113-Receptors, Serotonin,
pubmed-meshheading:10625113-Regression Analysis,
pubmed-meshheading:10625113-Serotonin Antagonists
|
pubmed:year |
1999
|
pubmed:articleTitle |
Enhanced platelet serotonin 5-HT2A receptor binding in anorexia nervosa and bulimia nervosa.
|
pubmed:affiliation |
Division of Clinical Pharmacology, Norrland University Hospital, Umeå, Sweden. olav.spigset@relis.rit.no
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|